Market News

Tygh Capital Management Trimmed By $3.93 Million Its Ligand Pharmaceuticals (LGND) Stake; Denver Investment Advisors Has Lowered Its Abbott Laboratories (ABT) Position

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Logo

Denver Investment Advisors Llc decreased Abbott Laboratories (ABT) stake by 5.39% reported in 2017Q4 SEC filing. Denver Investment Advisors Llc sold 18,115 shares as Abbott Laboratories (ABT)’s stock rose 5.88%. The Denver Investment Advisors Llc holds 318,152 shares with $18.16 million value, down from 336,267 last quarter. Abbott Laboratories now has $101.83B valuation. The stock decreased 0.90% or $0.53 during the last trading session, reaching $58.31. About 7.48 million shares traded or 4.29% up from the average. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 25, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Tygh Capital Management Inc decreased Ligand Pharmaceuticals (LGND) stake by 37.2% reported in 2017Q4 SEC filing. Tygh Capital Management Inc sold 28,930 shares as Ligand Pharmaceuticals (LGND)’s stock rose 20.51%. The Tygh Capital Management Inc holds 48,837 shares with $6.69 million value, down from 77,767 last quarter. Ligand Pharmaceuticals now has $3.43B valuation. The stock decreased 3.26% or $5.45 during the last trading session, reaching $161.77. About 236,989 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has risen 53.11% since April 25, 2017 and is uptrending. It has outperformed by 41.56% the S&P500.

Among 6 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Ligand Pharmaceuticals had 29 analyst reports since September 3, 2015 according to SRatingsIntel. H.C. Wainwright maintained the stock with “Buy” rating in Thursday, November 9 report. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) earned “Buy” rating by Craig Hallum on Wednesday, March 7. The company was maintained on Thursday, November 19 by TH Capital. The rating was maintained by Roth Capital on Monday, September 21 with “Buy”. As per Monday, July 17, the company rating was maintained by Deutsche Bank. The rating was maintained by Craig Hallum with “Buy” on Wednesday, November 15. Craig Hallum maintained it with “Buy” rating and $190.0 target in Thursday, February 22 report. The firm earned “Buy” rating on Monday, November 13 by Roth Capital. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has “Sell” rating given on Monday, November 20 by Deutsche Bank. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has “Buy” rating given on Friday, March 11 by Roth Capital.

Tygh Capital Management Inc increased Bright Horizons Family Solut (NYSE:BFAM) stake by 14,115 shares to 77,052 valued at $7.24 million in 2017Q4. It also upped Charles River Laboratories (NYSE:CRL) stake by 28,249 shares and now owns 64,356 shares. Foundaton Building Matieral was raised too.

Since December 20, 2017, it had 0 insider purchases, and 12 insider sales for $16.28 million activity. $1.41 million worth of stock was sold by HIGGINS JOHN L on Thursday, February 15. LAMATTINA JOHN L sold $536,604 worth of stock. The insider Aryeh Jason sold 7,500 shares worth $1.32M. On Monday, February 26 the insider Davis Todd C sold $2.62 million. 2,500 shares were sold by KOZARICH JOHN W, worth $362,500 on Wednesday, January 10. 5,444 shares valued at $832,824 were sold by FOEHR MATTHEW W on Friday, February 23. Shares for $112,414 were sold by Sabba Stephen L on Monday, March 12.

Investors sentiment decreased to 1.25 in 2017 Q4. Its down 0.44, from 1.69 in 2017Q3. It fall, as 21 investors sold LGND shares while 86 reduced holdings. 31 funds opened positions while 103 raised stakes. 22.68 million shares or 0.37% less from 22.76 million shares in 2017Q3 were reported. Northern Tru holds 0.01% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 311,584 shares. Deutsche National Bank Ag, a Germany-based fund reported 471,203 shares. Eagle Asset Management invested in 454,744 shares or 0.34% of the stock. Moreover, Eaton Vance Mngmt has 0.05% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). 140,000 were accumulated by State Of New Jersey Common Pension Fund D. Verity Asset Management holds 2,602 shares or 0.31% of its portfolio. Etrade Mngmt Lc invested 0.04% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Texas Permanent School Fund invested in 14,266 shares or 0.02% of the stock. First Tru Advsr Limited Partnership holds 12,513 shares. Fifth Third National Bank & Trust invested in 4,812 shares. 18,251 were accumulated by Nordea Mgmt Ab. D E Shaw & reported 0.01% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). 34,406 are held by Hsbc Hldgs Public Ltd. Adams Diversified Equity Fund holds 0.03% or 3,800 shares in its portfolio. Tocqueville Asset Mngmt Ltd Partnership holds 8,216 shares.

Analysts await Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) to report earnings on May, 8. They expect $1.11 EPS, up 184.62% or $0.72 from last year’s $0.39 per share. LGND’s profit will be $23.54 million for 36.43 P/E if the $1.11 EPS becomes a reality. After $1.03 actual EPS reported by Ligand Pharmaceuticals Incorporated for the previous quarter, Wall Street now forecasts 7.77% EPS growth.

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Wendell David has invested 1.98% in Abbott Laboratories (NYSE:ABT). Foothills Asset Mngmt Ltd holds 26,336 shares or 1.14% of its portfolio. Greenwood Capital Assocs Limited Company has 0.64% invested in Abbott Laboratories (NYSE:ABT). Eastern Bancorp holds 0.06% or 16,251 shares in its portfolio. City Co Fl reported 0.14% in Abbott Laboratories (NYSE:ABT). Hugh Johnson Ltd Liability Com has 1.12% invested in Abbott Laboratories (NYSE:ABT). Atlantic Tru Grp Limited Liability holds 1.80 million shares or 0.44% of its portfolio. Pura Vida Ltd Limited Liability Company invested 3.38% of its portfolio in Abbott Laboratories (NYSE:ABT). Chemical Retail Bank has invested 0.81% in Abbott Laboratories (NYSE:ABT). Barclays Public Ltd Co, United Kingdom-based fund reported 2.12M shares. Nichols Pratt Advisers Ltd Liability Partnership Ma has invested 0.32% in Abbott Laboratories (NYSE:ABT). Old Second State Bank Of Aurora holds 61,309 shares or 1.39% of its portfolio. Ifrah Fincl Service holds 0.42% of its portfolio in Abbott Laboratories (NYSE:ABT) for 20,174 shares. Old Mutual Customised Solutions (Proprietary) Limited stated it has 0.15% of its portfolio in Abbott Laboratories (NYSE:ABT). Security Bancshares Of So Dak invested 0.08% of its portfolio in Abbott Laboratories (NYSE:ABT).

Denver Investment Advisors Llc increased Education Realty Trust Inc (NYSE:EDR) stake by 89,458 shares to 473,139 valued at $16.52M in 2017Q4. It also upped Newell Brands Inc (NYSE:NWL) stake by 57,549 shares and now owns 224,537 shares. Glatfelter (NYSE:GLT) was raised too.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Buy” rating by RBC Capital Markets on Friday, September 1. As per Tuesday, October 10, the company rating was maintained by Jefferies. Argus Research maintained Abbott Laboratories (NYSE:ABT) on Friday, July 21 with “Buy” rating. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Thursday, October 19 with “Buy” rating. The firm has “Hold” rating given on Thursday, September 28 by Northland Capital. The rating was upgraded by Jefferies on Monday, December 7 to “Buy”. The rating was upgraded by BMO Capital Markets to “Outperform” on Tuesday, December 12. On Tuesday, January 2 the stock rating was upgraded by Morgan Stanley to “Overweight”. Credit Suisse reinitiated Abbott Laboratories (NYSE:ABT) rating on Monday, August 10. Credit Suisse has “Outperform” rating and $55 target. The firm earned “Buy” rating on Monday, April 17 by Cowen & Co.

Since December 14, 2017, it had 1 buy, and 18 sales for $23.52 million activity. Bracken Sharon J sold 2,100 shares worth $126,559. BIRD ROGER also sold $96,728 worth of Abbott Laboratories (NYSE:ABT) on Wednesday, February 28. Shares for $183,579 were sold by Watkin Jared. 1,220 shares valued at $71,970 were sold by Funck Robert E on Wednesday, February 28. 28,319 shares valued at $1.56 million were sold by Salvadori Daniel Gesua Sive on Thursday, December 14. STARKS DANIEL J also bought $2.43M worth of Abbott Laboratories (NYSE:ABT) shares. 1,430 Abbott Laboratories (NYSE:ABT) shares with value of $84,344 were sold by MANNING JOSEPH J.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *